Sacituzumab govitecan| ChemScene
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.In Vivo: Sacituzumab govitecan (IMMU-132) (17.5 mg/kg; twice weekly for 4 weeks) results in significant anti-tumor effects in mice bearing human gastric cancer xenografts.
| Trivial name | Sacituzumab govitecan |
| Catalog Number | CS-0182107 |
| Alternative Name(s) | IMMU-132 |
| Molecular Formula | 1000 |
| CAS# | 1491917-83-9 |
| Purity | >98% |
| Condensed Formula | N/A |
| Size | 5mg |
| Supplier Page | www.chemscene.com/1491917-83-9.html |